CAS: 913611-97-9
Molecular Formula: C25H27N3O2S
Molecular weight:433.57
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Brexpiprazole is a novel D2 dopamine and serotonin 1A partial agonist, called serotonin-dopamine activity modulator (SDAM), and a potent antagonist of serotonin 2A receptors, noradrenergic alpha 1B and 2C receptors. Brexpiprazole is approved for the treatment of schizophrenia, and as an adjunctive treatment for major depressive disorder (MDD).